In the same year, Gehrke et al found that Bcl3 promotes hepatic steatosis through modulation of peroxisome proliferator-activated receptor alpha (PPARα) and peroxisome proliferator-activated receptor-gamma coactivator (PGC-1α).30 This evidence concerns the gene PPARA and fatty liver disease.